42 scientists from Oslo University Hospital granted 69.2 mill NOK from the Norwegian Cancer Society
Oslo University Hospital (OUH) celebrated on Tuesday October 28th this year's research funding from the Norwegian Cancer Society (NCS). Talks were held by cured ex-lymphoma patient Ulf Prytz and scientist Hege Russnes. OUH general director Bjørn Erikstein and head of the Divison of Cancer Medicine, Surgery and Transplantation Sigmund Smeland thanked the NCS on behalf of the hospital. The projects granted support were announced by secretary-general in NCS Anne Lise Ryel. OUH received in total 69,2 mill NOK, distributed between 42 scientists.
Researchers supported by the NCS gathered during the celebration (click to enlarge) |
More photos from the event:
Large collection of excellent high-quality photos (NB - photos available in November 2014 only)
Photographer: Thomas Barstad Eckhoff
Projects granted supported by the Norwegian Cancer Society
Applicant | Project title |
Institution | Granted |
Sum |
Alseth, Ingrun | RNA modifications in cancer; the role of Endonuclease V | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 693 810 |
Anderson, Kristina | Clinical surveillance and therapeutic targeting of MDS stem cells | OUS | Running costs | 150 000 |
Bjørås, Magnar | Molykære mekansimer for DNA reparasjon | OUS | Technical position (3 years), Running costs | 1 945 813 |
Bogen, Bjarne | Idiotype-spesifikke T cellers cytotoksiske egenskaper overfor B lymfom celler in vivo og in vitro | OUS | Technical position (1 year), Running costs | 681 000 |
Boye, Kjetil | Circulating tumor DNA as a biomarker in gastrointestinal stromal tumor | OUS | Career Development Research Fellowship (3 years), Running costs | 1 421 360 |
Fodstad, Øystein | Tumor-og molekylærbiologiske studier av metastaser. Utvikling av nye diagnostiske og terapeutiske metoder | OUS | Running costs | 150 000 |
Gaustad, Jon-Vidar | Antiangiogenic treatment of malignant melanoma | OUS | Running costs | 100 000 |
Haglund, Kaisa | Cytokinesis and carcinogenesis | OUS | Running costs | 100 000 |
Heim, Sverre | Molecular cytogenetic analysis of carcinomas and brain tumors | OUS | Technical position (1 year), Running costs | 681 000 |
Hovig, Eivind | Metodeutvikling for molekylærbiologisk karakterisering og manipulering av metastaseprosessen | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 693 811 |
Klungland, Arne | Characterization of novel and known DNA modifications in cancer initiation and progression | OUS | Technical position (3 years), Running costs | 1 945 813 |
Krauss, Stefan | Tankyrase inhibition in personalized cancermedicine–defining patient inclusion criteria:tankyrase attenuating factors by shRNAbarcode screen | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 693 811 |
Kristensen, Vessela | The genetic Make-up and metabolic profile of breast cancer patients; relation to clinical course and treatment response | OUS | Technical position (3 years), Running costs | 1 945 813 |
Leithe, Edward | Rollen til ubiquitin og ubiquitin-liknende proteiner i nedregulering av tumorsuppressorproteiner ved utvikling av kolorektal kreft | OUS | Running costs | 100 000 |
Llorente, Alicia | Extracellular Vesicles and Prostate Cancer: In Search of Tumorigenesis Mechanisms and Biomarkers | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 693 811 |
Lothe, Ragnhild | Kreft, et resultat av genetiske og epigenetiske endringer. Modeller og mekanismer. | OUS | Technical position (3 years), Running costs | 2 095 813 |
Lyng, Heidi | Molecular biomarkers in radiotherapy of cancer | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 693 811 |
Malinen, Eirik | Personalized image guided therapy | OUS | Running costs | 100 000 |
Malmberg, Karl-Johan | Development of Cell Therapies for Malignant Lymphomas Based on New Insights Into Natural Killer Cell Repertoire Diversity | OUS | Running costs | 250 000 |
Meza Zepeda, Leonardo A | Genome-wide genetic and epigenetic programs in cancer | OUS | Running costs | 100 000 |
Micci, Francesca | Integrated genomic characterization of ovarian tumors | OUS | Running costs | 100 000 |
Moe, Morten | Epigenetic Basis of Human Uveal Melanoma as a Target for Future Therapy | OUS | Postdoctoral Research Fellowship (3 years) | 2 543 811 |
Myklebost, Ola | Mesenchymal Cancer Medicine | OUS | Technical position (3 years), Running costs | 1 945 813 |
Mælandsmo, Gunhild | Therapeutic approaches and molecular understanding of metastatic cancer | OUS | Running costs | 150 000 |
Naume, Bjørn | Targeting occult tumor cell dissemination in localized breast cancer | OUS | Technical position (3 years), Running costs | 1 945 813 |
OFarrell, Fergal | A model for investigating tumor microenvironment interactions in vivo | OUS | Career Development Research Fellowship (3 years) | 2 642 720 |
Patzke, Sebastian | Expression and Function of CSPP1 - From Molecular Cell Biology to Clinically Distinct Subtypes of Basal-like Breast Cancer | OUS | Running costs | 50 000 |
Raiborg, Camilla | ER-Endosome Contact: Implications for Tumour Suppressor Pathways, Cell Migration and Invasion | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 593 811 |
Rofstad, Einar | Tumor-Radiobiologi | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 693 811 |
Russnes, Hege Elisabeth | Intra tumor heterogeneity; from single cell analysis to diagnostic tools. | OUS | Postdoctoral Research Fellowship (3 years) | 2 543 811 |
Rusten, Tor Erik | Unveiling mechanisms of carcinogenesis using Drosophila melanogaster and human organoid models | OUS | Senior Research Fellowship (4.-7. year) | 3 719 244 |
Ruud, Ellen | Health impairments in young survivors after allogeneic haematopoietic stem cell transplantation | OUS | Running costs | 100 000 |
Sandvig, Kirsten | Endocytosis and intracellular sorting of protein toxins | OUS | Technical position (3 years), Running costs | 2 095 813 |
Skotheim, Rolf | Kvalitativ transkriptvariasjon i kreft | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 843 811 |
Smeland, Erlend B. | Biology of B cell lymphoma - identification of new diagnostic markers and targets for therapeutic intervention | OUS | Technical position (1 year), Running costs | 681 000 |
Stang, Espen | Targeting Cdc37 as a tool to down-regulate the oncoprotein ErbB2/HER2 | OUS | Running costs | 100 000 |
Stenmark, Harald | Cell division and cancer | OUS | Postdoctoral Research Fellowship (3 years), Technical position (3 years), Running costs | 4 739 624 |
Syljuåsen, Randi | DNA damage checkpoint signaling, hypoxia and radiation | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 693 811 |
Sørlie, Therese | Molecular portraits of breast cancer: Translating genomics to the clinical practice | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 643 811 |
Taskén, Kristin | Towards a potential role of beta-blockers in future cancer treatment - Filling the gaps | OUS | Postdoctoral Research Fellowship (3 years), Running costs | 2 643 811 |
Tveita, Anders | Establishing the mechanistic basis and dynamics of CD4+ anti-tumor immune responses | OUS | Career Development Research Fellowship (3 years) | 2 642 720 |
Wang, Junbai | Building next generation predictive models of gene regulation by incorporating diverse information | OUS | Running costs | 100 000 |
Wesche, Jørgen | Novel regulators of cancer cell migration | OUS | Senior Research Fellowship (7.-8. year) | 1 804 670 |
Amdal, Cecilie Delphin | Patient-reported outcomes in cancer patients; important both in clinical studies and clinical practise | OUS | Klinisk korttidsstipend (24 mnd) | 914 640 |
Dale, Einar | Prognostic value of PET-CT before radiotherapy of head & neck cancer | OUS | Klinisk korttidsstipend (24 mnd) | 914 640 |
Grotmol, Tom | Association between DNA methylation and the development of the metabolic syndrome after chemotherapy for testicular cancer | Kreftregisteret | Running costs | 100 000 |
Hofvind, Solveig | Understanding DCIS and which women are overdiagnosed | Kreftregisteret | Postdoctoral Research Fellowship (3 years) | 2 543 811 |
Møller, Bjørn | Prostate Cancer in Norway 2004-2011: Curative treatment and survival | Kreftregisteret | Postdoctoral Research Fellowship (3 years) | 2 543 811 |
Nygård, Mari | Advanced knowledge and technology challenge concepts in cervical cancer control: time to revisit existing cervical cancer screening program | Kreftregisteret | Postdoctoral Research Fellowship (3 years), Running costs | 2 693 811 |
Robsahm, Trude | Vitamin D, obesity and cutaneous malignant melanoma: risk, survival and risk of subsequent cancers | Kreftregisteret | Postdoctoral Research Fellowship (3 years), Running costs | 2 643 811 |